Related Experiment Video
Updated: Feb 3, 2026

Models of Bone Metastasis
Published on: September 4, 2012
Targeted Nanomedicine to Treat Bone Metastasis
Isaac M Adjei1, Madison N Temples2, Shannon B Brown3
1J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville 32611, FL, USA. adjeii@ufl.edu.
Abstract:
Bone metastases are common complications of solid tumors, particularly those of the prostate, breast, and lungs. Bone metastases can lead to painful and devastating skeletal-related events (SREs), such as pathological fractures and nerve compressions. Despite advances in treatment for cancers in general, options for bone metastases remain inadequate and generally palliative. Anticancer drugs (chemotherapy and radiopharmaceuticals) do not achieve therapeutic concentrations in the bone and are associated with dose-limiting side effects to healthy tissues. Nanomedicines, with their tunable characteristics, have the potential to improve drug targeting to bone metastases while decreasing side effects for their effective treatment. In this review, we present the current state of the art for nanomedicines to treat bone metastases. We also discuss new treatment modalities enhanced by nanomedicine and their effects on SREs and disease progression.
Insights
Nanomedicines offer a promising approach to treat bone metastases from solid tumors, improving drug delivery to bone and reducing side effects. This review explores current nanomedicine strategies for bone metastases and their impact on skeletal-related events.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Bone metastases are frequent complications of prostate, breast, and lung cancers.
- Skeletal-related events (SREs) like fractures and nerve compression significantly impact patient quality of life.
- Current treatments for bone metastases are often palliative and lack efficacy due to poor drug penetration and systemic toxicity.
Purpose of the Study:
- To review the current advancements in nanomedicine for treating bone metastases.
- To explore novel nanomedicine-enhanced treatment modalities for bone metastases.
- To discuss the impact of nanomedicines on SREs and cancer progression.
Main Methods:
- Literature review of nanomedicine applications in bone metastasis treatment.
- Analysis of nanomedicine characteristics relevant to bone targeting.
- Discussion of emerging nanomedicine-based therapeutic strategies.
Main Results:
- Nanomedicines demonstrate potential for enhanced drug targeting to bone metastases.
- Tunable properties of nanomedicines can improve therapeutic concentrations in bone.
- Reduced side effects on healthy tissues are achievable with targeted nanomedicine delivery.
Conclusions:
- Nanomedicines represent a significant advancement in the treatment of bone metastases.
- Targeted drug delivery via nanomedicine can improve outcomes and reduce SREs.
- Further research into nanomedicine modalities holds promise for effective bone metastasis management.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Bone Structure
Bone Remodeling
Compact Bone
Compact bone, also called cortical bone, is the denser, stronger of the two types of bone tissue. It is found under the periosteum and in the diaphyses of long bones, where it provides support and protection. The microscopic structural unit of compact bone is called an osteon, or haversian system. Each osteon is composed of concentric rings of calcified...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Hyoid Bone

